Funders Unmasked in 2017 Patent Suit Over Organon’s Nexplanon

A patent-holding firm seeking royalties from Nexplanon, a contraceptive implant whose US sales were nearly 10% of Merck & Co. spinoff Organon & Co.’s 2022 revenue, revealed in a court filing that two litigation funders are fueling Microspherix LLC’s 2017 infringement suit.

Microspherix is owned by Edward J. Kaplan, the sole named inventor of the asserted patents. No “person or entity” other than Microspherix has an ownership interest in any of them, the Boca Raton, Fla.-based company says in court filings.

But in a third-party litigation funding disclosure statement filed Wednesday in the US District Court for the District ...